Latest Period
Q1 2026
CUSIP: 90274D390
Latest Period
Q1 2026
Institutions Reporting
11
Shares (Excl. Options)
591,148
Price
$32.97
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 11 institutions filings for Q1 2026.
What is CUSIP 90274D390?
CUSIP 90274D390 identifies UCIB - UBS AG - ETRACS UBS BLOOM in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.
Use the next link that matches the question you still need to answer about this security.
Open recent reporting periods for CUSIP 90274D390:
As of 31 Mar 2026, 11 institutional investors reported holding 591,148 shares of UBS AG - ETRACS UBS BLOOM (UCIB).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 591,148 | $19,487,900 | +$2,634,039 | $32.97 | 11 |
| 2025 Q4 | 511,262 | $14,348,158 | +$203,100 | $28.06 | 10 |
| 2025 Q3 | 504,025 | $13,696,475 | +$1,052,878 | $27.17 | 10 |
| 2025 Q2 | 465,672 | $12,274,694 | +$646,564 | $26.36 | 10 |
| 2025 Q1 | 441,143 | $11,714,641 | +$558,347 | $26.56 | 10 |
| 2024 Q4 | 420,533 | $10,781,901 | -$281,225 | $25.76 | 9 |
| 2024 Q3 | 431,155 | $11,199,610 | -$1,748,702 | $25.97 | 11 |
| 2024 Q2 | 498,344 | $13,006,906 | +$554,464 | $26.10 | 12 |
| 2024 Q1 | 477,102 | $12,168,742 | +$203,160 | $25.51 | 10 |
| 2023 Q4 | 471,604 | $11,395,824 | +$755,776 | $24.16 | 11 |
| 2023 Q3 | 423,786 | $10,764,611 | -$448,882 | $25.40 | 7 |
| 2023 Q2 | 442,243 | $10,373,184 | -$569,009 | $23.45 | 8 |
| 2023 Q1 | 466,493 | $11,342,321 | +$496,621 | $24.32 | 8 |
| 2022 Q4 | 445,765 | $11,020,853 | -$2,824,782 | $24.72 | 9 |
| 2022 Q3 | 563,852 | $12,804,000 | -$306,967 | $22.71 | 11 |
| 2022 Q2 | 572,947 | $13,907,000 | +$1,523,340 | $24.27 | 12 |
| 2022 Q1 | 510,161 | $13,192,000 | -$44,438 | $25.86 | 10 |
| 2021 Q4 | 514,220 | $10,752,000 | -$243,861 | $20.91 | 11 |
| 2021 Q3 | 525,880 | $10,541,000 | -$1,027,322 | $20.04 | 11 |
| 2021 Q2 | 577,126 | $11,158,000 | -$15,004 | $19.33 | 10 |
| 2021 Q1 | 579,429 | $9,778,000 | -$681,045 | $16.87 | 9 |
| 2020 Q4 | 619,820 | $9,438,000 | -$381,402 | $15.23 | 7 |
| 2020 Q3 | 462,917 | $6,154,000 | -$72,837 | $13.30 | 7 |
| 2020 Q2 | 468,375 | $5,727,000 | +$1,739,003 | $12.24 | 6 |
| 2020 Q1 | 327,242 | $3,584,000 | +$3,584,000 | $10.93 | 6 |
| 2017 Q4 | 0 | $0 | -$181,000 | $32.97 | 0 |
| 2017 Q3 | 12,870 | $181,000 | +$181,000 | $14.06 | 1 |
| 2017 Q1 | 0 | $0 | -$32,000 | $32.97 | 0 |
| 2016 Q4 | 2,300 | $32,000 | +$32,000 | $13.91 | 1 |